Authors:
Guerra-Araiza, C
Reyna-Neyra, A
Salazar, AM
Cerbon, MA
Morimoto, S
Camacho-Arroyo, I
Citation: C. Guerra-araiza et al., Progesterone receptor isoforms expression in the prepuberal and adult malerat brain, BRAIN RES B, 54(1), 2001, pp. 13-17
Authors:
Wechsler, RJ
Salazar, AM
Gessner, AJ
Spirn, PW
Shah, RM
Steiner, RM
Citation: Rj. Wechsler et al., Case report - CT of in situ vascular stump thrombosis after pulmonary resection for cancer, AM J ROENTG, 176(6), 2001, pp. 1423-1425
Authors:
Bierley, RA
Drake, AI
Ahmed, S
Date, ES
Rosner, M
Warden, D
Salazar, AM
Citation: Ra. Bierley et al., Biased responding: a case series demonstrating a relationship between somatic symptoms and impaired recognition memory performance for traumatic brain injured individuals, BRAIN INJUR, 15(8), 2001, pp. 697-714
Authors:
Li, PP
Nakanishi, A
Shum, D
Sun, PCK
Salazar, AM
Fernandez, CF
Chan, SW
Kasamatsu, H
Citation: Pp. Li et al., Simian virus 40 Vp1 DNA-binding domain is functionally separable from the overlapping nuclear localization signal and is required for effective virion formation and full viability, J VIROLOGY, 75(16), 2001, pp. 7321-7329
Authors:
Warden, DL
Salazar, AM
Martin, EM
Schwab, KA
Coyle, M
Walter, J
Citation: Dl. Warden et al., A home program of rehabilitation for moderately severe traumatic brain injury patients, J HEAD TR R, 15(5), 2000, pp. 1092-1102
Authors:
Fischer, JS
Priore, RL
Jacobs, LD
Cookfair, DL
Rudick, RA
Herndon, RM
Richert, JR
Salazar, AM
Goodkin, DE
Granger, CV
Simon, JH
Grafman, JH
Lezak, MD
Hovey, KMO
Perkins, KK
Barilla-Clark, D
Schacter, M
Shucard, DW
Davidson, AL
Wende, KE
Bourdette, DN
Kooijmans-Coutinho, MF
Citation: Js. Fischer et al., Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis, ANN NEUROL, 48(6), 2000, pp. 885-892
Authors:
Simon, JH
Lull, J
Jacobs, LD
Rudick, RA
Cookfair, DL
Herndon, RM
Richert, JR
Salazar, AM
Sheeder, J
Miller, D
McCabe, K
Serra, A
Campion, MK
Fischer, JS
Goodkin, DE
Simonian, N
Lajaunie, M
Wende, K
Martens-Davidson, A
Kinkel, RP
Munschauer, FE
Citation: Jh. Simon et al., A longitudinal study of T1 hypointense lesions in relapsing MS - MSCRG trial of interferon beta-1a, NEUROLOGY, 55(2), 2000, pp. 185-192
Authors:
Johnson, PT
Wechsler, RJ
Salazar, AM
Fisher, AM
Nazarian, LN
Steiner, RM
Citation: Pt. Johnson et al., Spiral CT of acute pulmonary thromboembolism: Evaluation of pleuroparenchymal abnormalities, J COMPUT AS, 23(3), 1999, pp. 369-373
Authors:
Braverman, SE
Spector, J
Warden, DL
Wilson, BC
Ellis, TE
Bamdad, MJ
Salazar, AM
Citation: Se. Braverman et al., A multidisciplinary TBI inpatient rehabilitation programme for active dutyservice members as part of a randomized clinical trial, BRAIN INJUR, 13(6), 1999, pp. 405-415
Authors:
Rudick, RA
Cookfair, DL
Simonian, NA
Ransohoff, RM
Richert, JR
Jacobs, LD
Herndon, RM
Salazar, AM
Fischer, JS
Granger, CV
Goodkin, DE
Simon, JH
Bartoszak, DM
Bourdette, DN
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munchsauer, FE
O'Reilly, K
Priore, RL
Pullicino, PM
Scherokman, BJ
Wende, K
Weinstock-Guttman, B
Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
Authors:
Simon, JH
Jacobs, LD
Campion, MK
Rudick, RA
Cookfair, DL
Herndon, RM
Richert, JR
Salazar, AM
Fischer, JS
Goodkin, DE
Simonian, N
Lajaunie, M
Miller, DE
Wende, K
Martens-Davidson, A
Kinkel, RP
Munschauer, FE
Brownscheidle, CM
Citation: Jh. Simon et al., A longitudinal study of brain atrophy in relapsing multiple sclerosis, NEUROLOGY, 53(1), 1999, pp. 139-148
Authors:
Goodkin, DE
Priore, RL
Wende, KE
Campion, M
Bourdette, DN
Herndon, RM
Fischer, JS
Jacobs, LD
Cookfair, DL
Rudick, RA
Richert, JR
Salazar, AM
Granger, CV
Simon, JH
Alam, JJ
Bartoszak, DM
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munschauer, FE
Pullicino, PM
Scherokman, BJ
Weinstock-Guttman, B
Whitham, RH
Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486